Skip to main content
. 2018 Jun 6;8:8676. doi: 10.1038/s41598-018-26999-w

Figure 6.

Figure 6

The proposed model of lobohedleolide activity against HCV replication. Lobohedleolide reduced the HCV-induced COX-2 expression by downregulating the phosphorylation of JNK resulting in attenuation of the phosphorylation of c-Jun and the expression of C/EBP. Subsequently, the suppressed level of COX-2 and PGE2 by lobohedleolide lad to the inhibition of HCV replication.